Pfizer Inc. (NYSE:PFE) Cowen 43rd Annual Health Care Conference March 7, 2023 10:30 AM ET Company Participants Chris Stevo - SVP and Chief IR Officer Angela Hwang - CCO and President, Global Biopharmaceuticals Business Rodrigo Puga - U.S. Commercial and Global Business Lead for Internal Medicine Annaliesa Anderson - SVP and Chief Scientific Officer, Vaccine Research and Development Conference Call Participants Steve Scala - TD Cowen Steve Scala [Call Starts Abruptly] come back again this year. Representing ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-3619 PFIZER INC. (Exact name of registrant as specified in its charter) Delaware 13-5315170 (State or other jurisdiction of incorporation ...

Pfizer Inc. (NYSE:PFE) SVB Securities Global Biopharma Conference February 16, 2023 10:00 AM ET Company Participants Andy Schmeltz - Senior Vice President-Commercial Strategy & Innovation Navin Katyal - US Commercial & Global Business Lead-mRNA Conference Call Participants David Risinger - SVB Securities David Risinger Good morning, everybody, and thank you for participating in the final day of our SVB Global Healthcare Conference. My name is David Risinger. I cover diversified biopharmaceuticals, and it's ...

Fourth Quarter 2022 Earnings Teleconference January 31, 2023 Breakthroughs that change patients' lives ® Introduction Christopher Stevo Senior Vice President, Chief Investor Relations Officer Forward-Looking Statements and Non-GAAP Financial Information Our discussions during this conference call will include forward-looking statements that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We include fo ...

Pfizer Inc. (NYSE:PFE) Q4 2022 Results Conference Call January 31, 2023 10:00 AM ET Company Participants Chris Stevo - SVP and Chief IR Officer Dr. Albert Bourla - Chairman and CEO Dave Denton - CFO Dr. Mikael Dolsten - President, Worldwide Research, Development and Medical Angela Hwang - Chief Commercial Officer and President, Global Biopharmaceuticals Business Aamir Malik - Chief Business Innovation Officer Dr. William Pao - Chief Development Officer Conference Call Participants Louise Chen - Cantor Teren ...

Pfizer Inc. (NYSE:PFE) 41st Annual J.P. Morgan Healthcare Conference Call January 9, 2023 6:00 PM ET Company Participants Albert Bourla - Chairman & CEO Conference Call Participants Chris Schott - J.P. Morgan. Chris Schott Good afternoon. I'm Chris Schott at J.P. Morgan. And it's my pleasure to be hosting a fireside chat today with Albert Bourla, Chairman and CEO of Pfizer. So, Albert, Happy New Year. Thanks for joining us. Albert Bourla Happy New Year. Thank you very much. Chris Schott I know you want to m ...

Pfizer Inc. (NYSE:PFE) 4th Annual Wolfe Research Healthcare Conference Call November 18, 2022 8:45 AM ET Company Participants Dave Denton - Chief Financial Officer and Executive Vice President Chris Stevo - Investor Relations Conference Call Participants Tim Anderson - Wolfe Research Tim Anderson I am the large cap pharma analyst at Wolfe Research. And we are at the tail end of our Fourth Annual Healthcare Conference. Yes, I am doing a virtual fireside chat today with Pfizer. We had a two-day in-person meet ...

Pfizer Inc. (NYSE:PFE) Q3 2022 Earnings Conference Call November 1, 2022 10:00 AM ET Company Participants Christopher Stevo - SVP & Chief IR Officer Albert Bourla - Chairman & CEO David Denton - CFO & EVP Mikael Dolsten - President, Worldwide Research and Development and Medical Aamir Malik - Chief Business Innovation Officer Angela Hwang - Chief Commercial Officer and President, Global Biopharmaceuticals Business William Pao - EVP & Chief Development Officer Conference Call Participants Colin Bristow - UBS ...